Abstract
This chapter examines the discussion section of papers describing diagnostic test accuracy studies. It emphasizes the need to summarise key study results, discuss the clinical applicability of the results, and highlight any potential shortcomings and limitations of the study. A brief consideration of the vicissitudes of the publication process is also offered.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdel-Aziz K, Larner AJ. Six-Item Cognitive Impairment Test (6CIT) for detection of dementia and cognitive impairment. Int Psychogeriatr. 2015;27:991–7.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.
Bharambe V, Larner AJ. Functional cognitive disorders: memory clinic study. Prog Neurol Psychiatry. 2018a;22(3):19–22.
Bharambe V, Larner AJ. Functional cognitive disorders: demographic and clinical features contribute to a positive diagnosis. Neurodegener Dis Manag. 2018b;8:377–83.
Bossuyt PM, Reitsma JB, Bruns DE, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem. 2003;49:7–18.
Brodaty H, Low-Lee F, Gibson L, Burns K. What is the best dementia screening instrument for general practitioners to use? Am J Geriatr Psychiatry. 2006;14:391–400.
Brooke P, Bullock R. Validation of a 6 item cognitive impairment test with a view to primary care usage. Int J Geriatr Psychiatry. 1999;14:936–40.
Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Erlbaum; 1988.
Cohen J. A power primer. Psychol Bull. 1992;112:155–9.
Connon P, Larner AJ. Six-Item Cognitive Impairment Test (6CIT): diagnostic test accuracy study in primary care referrals. Int J Geriatr Psychiatry. 2017;32:583–4.
Cordell CB, Borson S, Boustani M, et al. Alzheimer’s Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting. Alzheimers Dement. 2013;9:141–50.
Crawford S, Whitnall L, Robertson J, Evans JJ. A systematic review of the accuracy and clinical utility of the Addenbrooke’s Cognitive Examination and the Addenbrooke’s Cognitive Examination-Revised in the diagnosis of dementia. Int J Geriatr Psychiatry. 2012;27:659–69.
Davis DH, Creavin ST, Noel-Storr A, et al. Neuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies. Cochrane Database Syst Rev. 2013;3:CD010460.
Delaney BC, Hyde CJ, McManus RJ, et al. Systematic review of near patient test evaluations in primary care. BMJ. 1999;319:824–7.
Duff K, Humphreys Clark JD, O’Bryant SE, Mold JW, Schiffer RB, Sutker PB. Utility of the RBANS in detecting cognitive impairment associated with Alzheimer’s disease: sensitivity, specificity, and positive and negative predictive powers. Arch Clin Neuropsychol. 2008;23:603–12.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
Gale TM, Larner AJ. Six-Item Cognitive Impairment Test (6CIT). In: Larner AJ, editor. Cognitive screening instruments. A practical approach. 2nd ed. London: Springer; 2017. p. 241–53.
Galvin JE, Fagan AM, Holtzman DM, Mintun MA, Morris JC. Relationship of dementia screening tests with biomarkers of Alzheimer’s disease. Brain. 2010;133:3290–300.
Gavett BE, Lou KR, Daneshvar DH, Green RC, Jefferson AL, Stern RA. Diagnostic accuracy statistics for seven Neuropsychological Assessment Battery (NAB) test variables in the diagnosis of Alzheimer’s disease. Appl Neuropsychol Adult. 2012;19:108–15.
Ghadiri-Sani M, Larner AJ. How to write a case report. Br J Hosp Med. 2014;75:207–10.
Gomar JJ, Bobes-Bascaran MT, Conejero-Goldberg C, Davies P, Goldberg TE. Utility of combinations of biomarkers, cognitive markers and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer’s disease neuroimaging initiative. Arch Gen Psychiatry. 2011;68:961–9.
Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25:3443–57.
Harrison JK, Fearon P, Noel-Storr AH, McShane R, Stott DJ, Quinn TJ. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a general practice (primary care) setting. Cochrane Database Syst Rev. 2014;7:CD010771.
Harrison JK, Fearon P, Noel-Storr AH, McShane R, Stott DJ, Quinn TJ. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care setting. Cochrane Database Syst Rev. 2015;3:CD010772.
Korevaar DA, Hooft L, Askie LM, et al. Facilitating prospective registration of diagnostic accuracy studies: a STARD initiative. Clin Chem. 2017;63:1331–41.
Landau SM, Harvey D, Madison CM, et al. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology. 2010;75:230–8.
Larner AJ. An audit of the Addenbrooke’s Cognitive Examination (ACE) in clinical practice. Int J Geriatr Psychiatry. 2005;20:593–4.
Larner AJ. Addenbrooke’s Cognitive Examination-Revised (ACE-R): pragmatic study of cross-sectional use for assessment of cognitive complaints of unknown aetiology. Int J Geriatr Psychiatry. 2013a;28:547–8.
Larner AJ. Comparing diagnostic accuracy of cognitive screening instruments: a weighted comparison approach. Dement Geriatr Cogn Dis Extra. 2013b;3:60–5.
Larner AJ. Effect size (Cohen’s d) of cognitive screening instruments examined in pragmatic diagnostic accuracy studies. Dement Geriatr Cogn Dis Extra. 2014;4:236–41.
Larner AJ. Optimizing the cutoffs of cognitive screening instruments in pragmatic diagnostic accuracy studies: maximising accuracy or Youden index? Dement Geriatr Cogn Disord. 2015a;39:167–75.
Larner AJ. Diagnostic test accuracy studies in dementia: a pragmatic approach. London: Springer; 2015b.
Larner AJ. Cognitive screening instruments. A practical approach. 2nd ed. London: Springer; 2017.
Larner AJ. Dementia in clinical practice: a neurological perspective. Pragmatic studies in the cognitive function clinic. 3rd ed. London: Springer; 2018a.
Larner AJ. Number needed to diagnose, predict, or misdiagnose: useful metrics for non-canonical signs of cognitive status? Dement Geriatr Cogn Dis Extra. 2018b;8:321–7.
Larner AJ. Evaluating cognitive screening instruments with the “likelihood to be diagnosed or misdiagnosed” measure. Int J Clin Pract. 2019a;73:e13265.
Larner AJ. MACE for diagnosis of dementia and MCI: examining cut-offs and predictive values. Diagnostics (Basel). 2019b;9:51.
Larner AJ. New unitary metrics for dementia test accuracy studies. Prog Neurol Psychiatry. 2019c;23:accepted.
Mallett S, Halligan S, Thompson M, Collins GS, Altman DG. Interpreting diagnostic accuracy studies for patient care. BMJ. 2012;344:e3999.
Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR. A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology. 2000;55:1613–20.
Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR. The Addenbrooke’s Cognitive Examination Revised: a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry. 2006;21:1078–85.
Mitchell AJ. The Mini-Mental State Examination (MMSE): an update on its diagnostic validity for cognitive disorders. In: Larner AJ, editor. Cognitive screening instruments. A practical approach. London: Springer; 2013. p. 15–46.
Mitchell AJ, Beaumont H, Ferguson D, Yadegarfar M, Stubbs B. Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis. Acta Psychiatr Scand. 2014;130:439–51.
Noel-Storr AH, Flicker L, Ritchie CW, et al. Systematic review of the body of evidence for use of biomarkers in the diagnosis of dementia. Alzheimers Dement. 2013;9:e96–105.
Noel-Storr AH, McCleery JM, Richard E, et al. Reporting standards for studies of diagnostic test accuracy in dementia: the STARDdem Initiative. Neurology. 2014;83:364–73.
O’Caoimh R, Gao Y, Svendovski A, Gallagher P, Eustace J, Molloy DW. Comparing approaches to optimize cut-off scores for short cognitive screening instruments in mild cognitive impairment and dementia. J Alzheimers Dis. 2017;57:123–33.
Pennington C, Newson M, Hayre A, Coulthard E. Functional cognitive disorder: what is it and what to do about it? Pract Neurol. 2015;15:436–44.
Quinn TJ, McShane R, Fearon P, Young C, Noel-Storr AH, Stott DJ. IQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a community setting. Cochrane Database Syst Rev. 2012;9:CD010079.
Reisberg B, Prichep L, Mosconi L, et al. The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer’s disease. Alzheimers Dement. 2008;4(1 Suppl 1):S98–108.
Richard E, Schmand BA, Eikelenboom P, Van Gool WA, The Alzheimer’s Disease Neuroimaging Initiative. MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer’s disease in patients with mild cognitive impairment: a diagnostic accuracy study. BMJ Open. 2013;3:e002541.
Rifai N, Altman DG, Bossuyt PM. Reporting bias in diagnostic and prognostic studies: time for action. Clin Chem. 2008;54:1101–3.
Sackett DL, Haynes RB. The architecture of diagnostic research. In: Knottnerus JA, editor. The evidence base of clinical diagnosis. London: BMJ Books; 2002. p. 19–38.
Schmidtke K, Pohlmann S, Metternich B. The syndrome of functional memory disorder: definition, etiology, and natural course. Am J Geriatr Psychiatry. 2008;16:981–8.
Schoenmaker N, Van Gool WA. The age gap between patients in clinical studies and in the general population: a pitfall for dementia research. Lancet Neurol. 2004;3:627–30.
Scottish Intercollegiate Guidelines Network. Methodology checklist 5: studies of diagnostic accuracy. In: A guideline developer’s handbook. Annex B. SIGN: Edinburgh; 2007.
Stone J, Pal S, Blackburn D, Reuber M, Thekkumpurath P, Carson A. Functional (psychogenic) cognitive disorders: a perspective from the neurology clinic. J Alzheimers Dis. 2015;48(Suppl1):S5–17.
van der Linde RM, Stephan BCM, Dening T, Brayne C. Instruments to measure behavioural and psychological symptoms of dementia. Int J Methods Psychiatr Res. 2014;23:69–98.
Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.
Whiting P, Rutjes AW, Dinnes J, Reitsma J, Bossuyt PM, Kleijnen J. Development and validation of methods for assessing the quality of diagnostic accuracy studies. Health Technol Assess. 2004;8:iii,1–234.
Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–36.
Williamson JC, Larner AJ. “Likelihood to be diagnosed or misdiagnosed”: application to meta-analytic data for cognitive screening instruments. Neurodegener Dis Manag. 2019;9:91–5.
Wilson C, Kerr D, Noel-Storr A, Quinn TJ. Associations with publication and assessing publication bias in dementia diagnostic test accuracy studies. Int J Geriatr Psychiatry. 2015;30:1250–6.
Ziso B, Larner AJ. AD8: Likelihood to diagnose or misdiagnose. Poster presentation, Association of British Neurologists, Edinburgh, 21–23 May 2019a.
Ziso B, Larner AJ. Codex (cognitive disorders examination) decision tree modified for the detection of dementia and MCI. Diagnostics (Basel). 2019b;9:58.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Larner, A.J. (2019). Discussion. In: Diagnostic Test Accuracy Studies in Dementia. Springer, Cham. https://doi.org/10.1007/978-3-030-17562-7_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-17562-7_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-17561-0
Online ISBN: 978-3-030-17562-7
eBook Packages: MedicineMedicine (R0)